Delivery Order SPE2DB20D2104-SPE2DB26FMAZK
- Not listed
- The Defense Logistics Agency awarded a $31,772.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of July 17, 2025. This competitive award, issued on July 16, 2025, carries a firm fixed price and involves no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary distribution and pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $9,268.54 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, non-set-aside contract was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The firm fixed price delivery order represents a continuation of AmerisourceBergen's pharmaceutical supply...
- The Defense Logistics Agency awarded a $23,564.75 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,438.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The award was issued on July 11, 2025, with an ultimate completion date of July 14, 2025, and represents a competitively awarded contract with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,513.23 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials, with a completion date of September 15, 2025. The contract was competitively awarded on September 12, 2025, with firm fixed pricing and no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $30,496.07 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed price contract with an ultimate completion date of August 8, 2025, and represents a competitively awarded, non-set-aside procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,117.49 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by August 18, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order was issued under a non-set-aside procurement, reflecting open competition among qualified pharmaceutical distributors. This award...
- The Defense Logistics Agency awarded a delivery order valued at $45,468.54 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,833.28 on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with completion scheduled for October 28, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $46,093.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAZKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,192.38 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's broader federal contract portfolio supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle supports comprehensive global pharmaceutical supply to military healthcare programs and serves customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's contract awards demonstrate proven capability to supply a diverse range of pharmaceutical products, including specialty diabetes medications like Ozempic, through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 10/27/25 |